PUBLICATIONS

• Articles
• Brochures
• Meeting Abstracts

Latest publications

1. Beekman CA, Buckle T, van Leeuwen AC, Valdés Olmos RA, Verheij M, Rottenberg S, van Leeuwen FW. Questioning the value of (99m)Tc-HYNIC-annexin V based response monitoring after docetaxel treatment in a mouse model for hereditary breast cancer. 2011. Appl. Radiat. Isot. 69(4): 656-62.
2. Bergmann TK, H Gréen, C Brasch-Andersen, MR Mirza, J Herrstedt, B Hølund, P Damkier, W Vach, K Brosen and C Peterson. Retrospective study of the impact of pharmacogenetic variants on paclitaxel toxicity in ovarian cancer. 2011. European J. Clinical Pharmacology. DOI: 10.1007/s00228-011-1007-6
3. Bergmann TK, C Brasch-Andersen, H Gréen, MR Mirza, RS Pedersen, F Nielsen, K Skougaard, J Wihl, N Keldsen, P Damkier, LE Friberg, C Peterson, W Vach, MO Karlsson and K Brosen. Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer. 2011. In Press The Pharmacogenomics Journal. [Epub ahead of print] Apr 6^th 2010.